| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Tuesday - Mar 18, 2025 |
|||||||||
|
HealthEquity
HQY
|
Q4 FY25 | $0.69 | $0.71 | $311.82M | $305.82M |
NASDAQ |
|||
|
Citi Trends
CTRN
|
Q4 FY24 | -$1.55 | $0.18 | $211.17M | $195.63M |
NASDAQ |
|||
|
Bitcoin Depot
BTM
|
Q4 FY24 | -$1.47 | $0.18 | $136.83M | $131.50M |
NASDAQ |
|||
|
Maravai LifeSciences Holdings
MRVI
|
- | -$0.06 | -$0.03 | $56.41M | $57.79M |
NASDAQ |
|||
|
Surf Air Mobility
SRFM
|
Q4 FY24 | $0.59 | -$1.19 | $28.05M | $26.78M |
NYSE |
|||
|
Aterian
ATER
|
Q4 FY24 | -$0.18 | -$0.51 | $24.61M | $23.48M |
NASDAQ |
|||
|
Sound Financial Bancorp
SFBC
|
- | $0.75 | - | $15.92M | - |
NASDAQ |
|||
|
Eton Pharmaceuticals
ETON
|
Q4 FY24 | -$0.02 | -$0.02 | $11.65M | $14.33M |
NASDAQ |
|||
|
Aadi Bioscience
AADI
|
- | -$0.67 | -$0.30 | $7.24M | $7.44M |
NASDAQ |
|||
|
OmniAb
OABI
|
Q4 FY24 | -$0.12 | -$0.13 | $10.80M | $6.53M |
NASDAQ |
|||
|
Absci
ABSI
|
Q4 FY24 | -$0.25 | -$0.22 | $665K | $4.87M |
NASDAQ |
|||
|
Stoke Therapeutics
STOK
|
- | -$0.18 | -$0.51 | $22.61M | $3.86M |
NASDAQ |
|||
|
Tonix Pharmaceuticals Holding
TNXP
|
- | -$9.77 | -$6.23 | $2.58M | $3.20M |
NASDAQ |
|||
|
Kronos Bio
KRON
|
- | -$0.43 | -$0.30 | $2.27M | $2.42M |
NASDAQ |
|||
|
Korro Bio
KRRO
|
- | -$2.26 | -$2.33 | $2.27M | - |
NASDAQ |
|||
|
Coya Therapeutics
COYA
|
- | -$0.18 | -$0.26 | $1.95K | $100K |
NASDAQ |
|||
|
Inovio Pharmaceuticals
INO
|
Q4 FY24 | -$0.69 | -$0.87 | $116.99K | $50K |
NASDAQ |
|||
|
Lightwave Logic
LWLG
|
- | -$0.05 | - | $22.92K | - |
NASDAQ |
|||
|
Olema Pharmaceuticals
OLMA
|
- | -$0.51 | -$0.63 | - | - |
NASDAQ |
|||
|
XBiotech
XBIT
|
- | -$0.34 | - | - | - |
NASDAQ |
|||
|
Exicure
XCUR
|
- | -$3.39 | - | - | - |
NASDAQ |
|||
|
MiNK Therapeutics
INKT
|
Q4 FY24 | -$0.62 | -$0.50 | - | - |
NASDAQ |
|||
|
Trevi Therapeutics
TRVI
|
Q4 FY24 | -$0.11 | -$0.12 | - | - |
NASDAQ |
|||
| Show 13 more companies | |||||||||
